Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients
- 1 May 1989
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 25 (5), 899-903
- https://doi.org/10.1016/0277-5379(89)90138-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Lack of effect of cisplatin on i. v. L-PAM plasma pharmacokinetics in ovarian cancer patientsCancer Chemotherapy and Pharmacology, 1988
- Quantitative determination of melphalan in plasma by liquid chromatography after derivatization with N-acetylcysteineJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresisCancer Chemotherapy and Pharmacology, 1986
- High dose melphalan in children with advanced malignant diseaseCancer Chemotherapy and Pharmacology, 1985
- Multiple myeloma: Current therapy and a glimpse of the futureScandinavian Journal of Haematology, 1985
- Controversies in the treatment of plasma cell myelomaPublished by Oxford University Press (OUP) ,1985
- Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalanBritish Journal of Cancer, 1981
- Oral melphalan kineticsClinical Pharmacology & Therapeutics, 1979
- Kinetics of intravenous melphalanClinical Pharmacology & Therapeutics, 1979
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975